CD40 Enhances Sphingolipids in Orbital Fibroblasts: Potential Role of Sphingosine-1-Phosphate in Inflammatory T-Cell Migration in Graves' Orbitopathy
Author(s) -
Svenja Plöhn,
Bärbel Edelmann,
Lukasz Japtok,
Xingxuan He,
Matthias Hose,
Wiebke Hansen,
Edward H. Schuchman,
Anja Eckstein,
Utta BerchnerPfannschmidt
Publication year - 2018
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.18-25466
Subject(s) - sphingosine , sphingosine 1 phosphate , lipid signaling , ceramide , chemistry , sphingosine kinase , cd40 , sphingolipid , cd154 , inflammation , microbiology and biotechnology , sphingosine kinase 1 , receptor , fibroblast , endocrinology , medicine , biology , biochemistry , cytotoxic t cell , apoptosis , in vitro
Graves' orbitopathy (GO) is an autoimmune orbital disorder associated with Graves' disease caused by thyrotropin receptor autoantibodies. Orbital fibroblasts (OFs) and CD40 play a key role in disease pathogenesis. The bioactive lipid sphingosine-1-phosphate (S1P) has been implicated in promoting adipogenesis, fibrosis, and inflammation in OFs. We investigated the role of CD40 signaling in inducing S1P activity in orbital inflammation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom